Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Björn Pasternak

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
JAMA|August 26, 2010
Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defectsBjörn Pasternak, Anders Hviid
Acta Orthopaedica|December 9, 2009
Metalloproteinases and their inhibitors-diagnostic and therapeutic opportunities in orthopedicsBjörn Pasternak, Per Aspenberg
The New England Journal of Medicine|November 26, 2010
Use of proton-pump inhibitors in early pregnancy and the risk of birth defectsBjörn Pasternak, Anders Hviid
BMJ (Clinical Research Ed.)|February 26, 2025
GLP-1 receptor agonists and suicidalityPeter Ueda, Björn Pasternak
Archives of Internal Medicine|February 18, 2011
Atovaquone-proguanil use in early pregnancy and the risk of birth defectsBjörn Pasternak, Anders Hviid
JAMA Pediatrics|September 28, 2020
Proton Pump Inhibitors and Fractures During Growth-ReplyYun-Han Wang, Björn Pasternak
JAMA|April 13, 2012
Association of treatment with losartan vs candesartan and mortality among patients with heart failureHenrik Svanström, Björn Pasternak, Anders Hviid
Annals of the Rheumatic Diseases|March 22, 2014
Use of strontium ranelate and risk of acute coronary syndrome: cohort studyHenrik Svanström, Björn Pasternak, Anders Hviid
JAMA Internal Medicine|April 7, 2015
β-Blockers in diabetic patients with heart failure--replyBjörn Pasternak, Henrik Svanström, Anders Hviid
The New England Journal of Medicine|May 3, 2013
Use of azithromycin and death from cardiovascular causesHenrik Svanström, Björn Pasternak, Anders Hviid
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
JAMA|August 26, 2010
Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defectsBjörn Pasternak, Anders Hviid
Acta Orthopaedica|December 9, 2009
Metalloproteinases and their inhibitors-diagnostic and therapeutic opportunities in orthopedicsBjörn Pasternak, Per Aspenberg
The New England Journal of Medicine|November 26, 2010
Use of proton-pump inhibitors in early pregnancy and the risk of birth defectsBjörn Pasternak, Anders Hviid
BMJ (Clinical Research Ed.)|February 26, 2025
GLP-1 receptor agonists and suicidalityPeter Ueda, Björn Pasternak
Archives of Internal Medicine|February 18, 2011
Atovaquone-proguanil use in early pregnancy and the risk of birth defectsBjörn Pasternak, Anders Hviid
JAMA Pediatrics|September 28, 2020
Proton Pump Inhibitors and Fractures During Growth-ReplyYun-Han Wang, Björn Pasternak
JAMA|April 13, 2012
Association of treatment with losartan vs candesartan and mortality among patients with heart failureHenrik Svanström, Björn Pasternak, Anders Hviid
Annals of the Rheumatic Diseases|March 22, 2014
Use of strontium ranelate and risk of acute coronary syndrome: cohort studyHenrik Svanström, Björn Pasternak, Anders Hviid
JAMA Internal Medicine|April 7, 2015
β-Blockers in diabetic patients with heart failure--replyBjörn Pasternak, Henrik Svanström, Anders Hviid
The New England Journal of Medicine|May 3, 2013
Use of azithromycin and death from cardiovascular causesHenrik Svanström, Björn Pasternak, Anders Hviid
Pageof 12